tirzepatide latest news New weight loss drug could break sales records FDA approves new version of

Lucia MS, Torkko KC

Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking Wegovy Adverse Reactions Most common adverse reactions (incidence 5%) are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with T2D, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss Drug Interactions When initiating Wegovy , consider reducing the dose of concomitantly administered insulin secretagogues or insulin to reduce the risk of hypoglycemia

The amount of weight lost was crazy, I loved the program

We dont actually know, says Simon C

Many providers recommend against semaglutide during breastfeeding out of caution, particularly in the early months when breastfeeding is being established and infant exposure would be highest

Consider staying at 7.5 mg if: You are losing 1 to 2 pounds per week consistently Appetite suppression is adequate to maintain a caloric deficit Side effects are minimal and manageable You are comfortable with the cost at this dose level Consider continuing to 10 mg if: Weight loss has plateaued for more than 3 weeks at 7.5 mg Appetite suppression has diminished significantly Your target weight is still far from current weight Side effects at 7.5 mg are mild and tolerable Many researchers use the troubleshooting guide to determine whether a dose increase is the right move or whether other factors like dietary compliance or sleep quality are affecting results